Bugelski; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bugelski; Peter.The latest application filed is for "method of treating erythropoietin hyporesponsive anemias".
- Bugelski; Peter - Pottstown PA
- Bugelski; Peter - Radnor PA
- Bugelski; Peter - Malvem PA
- Bugelski, Peter - Coventryville PA
| Patent | Date |
|---|---|
| CXCL13 antagonists and their use for the treatment of inflammatory diseases Grant 8,277,809 - Bugelski , et al. October 2, 2 | 2012-10-02 |
| Method Of Treating Erythropoietin Hyporesponsive Anemias App 20100266591 - Bugelski; Peter ; et al. | 2010-10-21 |
| CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases App 20090136512 - Bugelski; Peter ; et al. | 2009-05-28 |
| CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases App 20080014201 - Bugelski; Peter ; et al. | 2008-01-17 |
| Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription App 20030224407 - Bertram, Timothy ; et al. | 2003-12-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 